BOSTON – A nurse at the Department of Correction’s
Massachusetts Alcohol and Substance Abuse Center (MASAC) in Plymouth pleaded
guilty today in federal court in Boston to distributing Suboxone pills to
inmates in that facility.
Julie Inglis-Somers, 39, of Kingston, Mass., pleaded guilty
to distribution of a controlled substance. U.S. District Court Judge Indira
Talwani scheduled sentencing for Oct. 24, 2019. In December 2018, Inglis-Somers
was charged by criminal complaint and arrested in Jacksonville, Fla. after
fleeing the District of Massachusetts. She was indicted in January 2019.
On or about Nov. 18, 2018, and Dec. 4, 2018, Inglis-Somers
provided Suboxone strips and pills to two inmates at MASAC. Suboxone, a Class
III controlled substance used to treat heroin addiction, is sometimes misused
to get high. Suboxone is a coveted contraband in prisons across the nation and
is particularly popular in New England.
MASAC is one of five facilities in Massachusetts where,
under Massachusetts General Laws, a state court judge can send a person who the
judge has determined to be a danger to themselves or to others due to substance
abuse. MASAC is the only such facility overseen by the Massachusetts Department
of Corrections.
The charge of distribution of a controlled substance
provides for a sentence of no greater than 10 years in prison, three years of
supervised release and a fine of $500,000. Sentences are imposed by a federal
district court judge based upon the U.S. Sentencing Guidelines and other
statutory factors.
United States Attorney Andrew E. Lelling; Joseph R.
Bonavolonta, Special Agent in Charge of the Federal Bureau of Investigation,
Boston Field Division; and Commissioner Carol Mici of the Massachusetts
Department of Correction made the announcement today. The FBI Jacksonville (FL)
Field Division and the Suwannee County (FL) Sheriff’s Office provided
assistance with the arrest. Assistant U.S. Attorney Eugenia M. Carris of
Lelling’s Public Corruption and Special Prosecutions Unit is prosecuting the
case.
No comments:
Post a Comment